Sava Healthcare
Pune, India· Est.
India‑based CDMO and product developer excelling in nasal and inhalation drug delivery across human and veterinary markets.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
India‑based CDMO and product developer excelling in nasal and inhalation drug delivery across human and veterinary markets.
RespiratoryAllergyDermatologyVeterinaryHerbal Medicine
Technology Platform
Specialized formulation and delivery platform for nasal sprays, dry‑powder inhalers, and topical dosage forms, supported by advanced analytical and process‑validation capabilities.
Opportunities
Expansion of USFDA‑accredited manufacturing, growth in nasal/inhalation therapeutics, and increasing demand for animal health and Ayurvedic products in emerging markets.
Risk Factors
Regulatory compliance pressures, competition from larger CDMOs, and potential raw‑material supply disruptions.
Competitive Landscape
Competes with Indian CDMOs such as Cipla, Sun Pharma, and Lupin, differentiating through niche expertise in nasal and inhalation delivery and a diversified animal‑health and herbal portfolio.